Direct Dirigeants by NewCap invites you to their event

MaaT Pharma’s Phase 3 Positive Topline Results Call for MaaT013 in acute Graft-versus-Host Disease

January 09, 2025 16:00 (CET)
About 1 hour

About this event

Following the positive Phase 3 topline results for MaaT013, with the study achieving its primary endpoint, Hervé Affagard (CEO and co-founder), Gianfranco Pittari, MD, PhD (CMO), Eric Soyer (CFO) and Sian Crouzet (Chief of Staff) will discuss the impact of the ARES Phase 3 results and their implications for MaaT Pharma during a Company Call and webcast.



Hosted by

  • Guest speaker
    G
    Hervé Affagard CEO and co-founder @ MaaT Pharma

  • Guest speaker
    G
    Eric Soyer Chief Financial Officer @ MaaT Pharma

  • Guest speaker
    G
    Sian Crouzet Chief of Staff @ MaaT Pharma

  • Guest speaker
    G
    Gianfranco Pittari MD, PhD Chief Medical Officer @ MaaT Pharma

Direct Dirigeants by NewCap

La plateforme d’échanges avec les dirigeants de sociétés cotées en bourse

NewCap a conçu une plateforme d’événements sur mesure pour créer, enrichir et pérenniser la relation entre les sociétés cotées et leurs actionnaires.

View all events
Host webinars on Host webinars on Livestorm
Virtual Meetings ∙ Webinars ∙ Virtual Events ∙ On-Demand Webinars ∙ Automated Webinars ∙ Product Demos ∙ Company communication ∙ Customer training ∙ Live Q&As ∙ Employee onboarding ∙ Live events